Effect of Domperidone on QT Interval in Premature Infants

Prematurity and Feeding Intolerance Clinical Trial

Official title: Effect of Domperidone on QT Interval in Premature Infants

Status Completed

Clinical Trial Summary

30 premature infants treated by domperidone upon decision of the attending neonatologist will have a daily recording of electrocardiogram for the first 7 seven days of treatment, and pharmacokinetics dosages at Day 7. Their ECG will be compared to 30 non treated premature infants, matched for gestational age, postnatal age and sex.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Premature Birth
• Prematurity and Feeding Intolerance

• NCT number: NCT00238056
• Study type: Interventional
• Source: Nantes University Hospital
• Status: Completed
• Phase: Phase 2